<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Cerebral Signal Intensity Abnormalities on T2-weighted MR Images in HIV Patients with Highly Active Antiretroviral Therapy" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/cerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/cerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2011-08-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Cerebral Signal Intensity Abnormalities on T2-weighted MR Images in HIV Patients with Highly Active Antiretroviral Therapy" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2011-08-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Cerebral Signal Intensity Abnormalities on T2-weighted MR Images in HIV Patients with Highly Active Antiretroviral Therapy","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/cerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active/"},"url":"https://clinicaltree.github.io/posts/cerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active/"}</script><title>Cerebral Signal Intensity Abnormalities on T2-weighted MR Images in HIV Patients with Highly Active Antiretroviral Therapy | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Cerebral Signal Intensity Abnormalities on T2-weighted MR Images in HIV Patients with Highly Active Antiretroviral Therapy</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Cerebral Signal Intensity Abnormalities on T2-weighted MR Images in HIV Patients with Highly Active Antiretroviral Therapy</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1314810000" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Aug 31, 2011 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Uta Hanning MD</a> </em>, <em> <a href="">Ingo W. Husstedt MD</a> </em>, <em> <a href="">Thomas-Ulrich Niederstadt MD</a> </em>, <em> <a href="">Stefan Evers MD PhD</a> </em>, <em> <a href="">Walter Heindel MD</a> </em>, <em> <a href="">Stephan P. Kloska MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2009 words"> <em>11 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The aim of this study was to assess the relationship between immune state and cerebral signal intensity abnormalities (SIAs) on T2-weighted magnetic resonance images in subjects with human immunodeficiency virus type 1 infection and highly active antiretroviral therapy.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Thirty-two subjects underwent a total of 109 magnetic resonance studies. The presence of human immunodeficiency virus–associated neurocognitive disorder, categorized CD4 + T lymphocyte count, and plasma viral load were assessed for relationship with the severity and interval change of SIAs for different anatomic locations of the brain.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Subjects with multifocal patterns of SIAs had CD4 + cell counts &lt; 200 cells/μL in 66.0%, whereas subjects with diffuse patterns of SIAs had CD4 + cell counts &lt; 200 cells/μL in only 31.4% ( <em>P</em> &lt; .001). Subjects without SIAs in the basal ganglia had CD4 + cell counts &lt; 200 cells/μL in 37.0%, whereas subjects with minor and moderate SIAs in the basal ganglia had CD4 + cell counts &lt; 200 cells/μL in 78.3% and 80.0%, respectively ( <em>P</em> &lt; .005). The percentage of subjects with CD4 + cell counts &lt; 200 cells/μL was 85.7% when there were progressive periventricular SIA changes and 45.5% when periventricular SIA changes were stable in follow-up ( <em>P</em> &lt; .05).</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The presence and progression of cerebral SIAs on T2-weighted magnetic resonance images reflecting cerebral infection with human immunodeficiency virus are significantly related to impaired immune state as measured by CD4 + cell count.</p><p>Central nervous system (CNS) involvement often occurs as part of human immunodeficiency virus (HIV) infection. This concerns not only the incidence of opportunistic CNS infections but in particular the direct CNS manifestation of HIV infection . Usually, in 10% of all HIV-infected and acquired immunodeficiency syndrome (AIDS) patients, neurologic complaints are the initial clinical manifestation, and an additional 30% to 60% of all patients will develop neurologic symptoms during the course of the infection . Cerebrospinal fluid analysis has demonstrated that HIV enters the CNS soon after exposure, even before antibodies are detectable in blood .</p><p>In the past, different patterns of changes in cerebral magnetic resonance (MR) imaging (MRI) in HIV infection have been described . MRI studies have provided in vivo evidence of white matter abnormalities on T2-weighted MR images in HIV type 1 , and reduced cerebral white matter volume has been reported in advanced disease stages . However, knowledge is limited about signal intensity abnormalities (SIAs) on T2-weighted MR images in subjects with HIV since the introduction of highly active antiretroviral therapy (HAART) in HIV treatment 15 years ago. In small study populations, MRI has been demonstrated to characterize cerebral changes during the course of HAART in patients with AIDS . Nevertheless, little information is available on the relationship of neuroclinical status and the distribution of white matter lesions in patients with HIV and AIDS receiving HAART.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population"><span class="mr-2">Study Population</span><a href="#study-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-parameters"><span class="mr-2">Clinical Parameters</span><a href="#clinical-parameters" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-protocol"><span class="mr-2">Imaging Protocol</span><a href="#imaging-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Scan Parameters of the MR Systems Used in the Study</p><p>Scanner TR (ms) TE (ms) FOV (mm) Matrix (mm) ST (mm) NSA Magnetom Impact 1.0 T ∗ 3000 85 230 × 230 250 × 256 5 2 Magnetom Expert 1.5 T ∗ 4000 90 230 × 230 252 × 256 5 2 Magnetom Vision 1.5 T ∗ 2700 90 230 × 230 192 × 256 5 2 Intera Gyroscan 1.5 T † 4500 100 230 × 230 299 × 512 6 2 Intera Gyroscan 3.0 T † 3000 80 230 × 230 319 × 512 4 1</p><p>FOV, field of view; MR, magnetic resonance; NSA, number of signal acquisitions; ST, slice thickness, TE, echo time; TR, repetition time.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Grading Scales of Image Analysis</p><p>Description Scale Pattern of signal intensity abnormalities None Multifocal Diffuse Severity of signal intensity abnormalities ∗ None Mild (&lt;25%) Moderate (25%–75%) Severe (&gt;75%)</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population-1"><span class="mr-2">Study Population</span><a href="#study-population-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="descriptive-statistics"><span class="mr-2">Descriptive Statistics</span><a href="#descriptive-statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Descriptive Statistics</p><p>Severity of Signal Intensity Abnormalities HAND χ 2 <em>P</em> Value Yes No Pattern .340 None 0 (0.0%) 0 (0.0%) Multifocal 36 (35.6%) 18 (17.8%) Diffuse 27 (26.7%) 20 (19.8%) Periventricular white matter .119 None 10 (9.9%) 14 (13.9%) Mild 36 (35.6%) 17 (16.8%) Moderate 9 (8.9%) 4 (4.0%) Severe 8 (7.9%) 3 (3.0%) Basal ganglia .083 None 40 (39.6%) 32 (31.7%) Mild 19 (18.8%) 5 (5.0%) Moderate 4 (4.0%) 1 (1.0%) Severe 0 (0.0%) 0 (0.0%) Posterior fossa .220 None 38 (37.6%) 29 (28.7%) Mild 24 (23.8%) 9 (8.9%) Moderate 1 (1.0%) 0 (0.0%) Severe 0 (0.0%) 0 (0.0%)</p><p>HAND, human immunodeficiency virus–associated neurocognitive disorder.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="correlation-statistics"><span class="mr-2">Correlation Statistics</span><a href="#correlation-statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CerebralSignalIntensityAbnormalitiesonT2weightedMRImagesinHIVPatientswithHighlyActiveAntiretroviralTherapy/0_1s20S107663321100239X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CerebralSignalIntensityAbnormalitiesonT2weightedMRImagesinHIVPatientswithHighlyActiveAntiretroviralTherapy/0_1s20S107663321100239X.jpg" alt="Figure 1, Relationship between categorized CD4 + cell count and pattern of signal intensity abnormalities (SIAs). The χ 2 test was significant ( P &lt; .001)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CerebralSignalIntensityAbnormalitiesonT2weightedMRImagesinHIVPatientswithHighlyActiveAntiretroviralTherapy/1_1s20S107663321100239X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CerebralSignalIntensityAbnormalitiesonT2weightedMRImagesinHIVPatientswithHighlyActiveAntiretroviralTherapy/1_1s20S107663321100239X.jpg" alt="Figure 2, Relationship between categorized CD4 + cell count and signal intensity abnormalities (SIAs) in the basal ganglia. The χ 2 test was significant ( P &lt; .005)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CerebralSignalIntensityAbnormalitiesonT2weightedMRImagesinHIVPatientswithHighlyActiveAntiretroviralTherapy/2_1s20S107663321100239X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CerebralSignalIntensityAbnormalitiesonT2weightedMRImagesinHIVPatientswithHighlyActiveAntiretroviralTherapy/2_1s20S107663321100239X.jpg" alt="Figure 3, Relationship between dichotomized CD4 + cell count and interval change of periventricular signal intensity abnormalities (SIAs). The χ 2 test was significant ( P &lt; .05)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="relationship-with-pattern-and-location-of-sias"><span class="mr-2">Relationship with Pattern and Location of SIAs</span><a href="#relationship-with-pattern-and-location-of-sias" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="relationship-with-changes-of-sia-severity-on-follow-up"><span class="mr-2">Relationship with Changes of SIA Severity on Follow-up</span><a href="#relationship-with-changes-of-sia-severity-on-follow-up" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="limitations-of-this-study"><span class="mr-2">Limitations of This Study</span><a href="#limitations-of-this-study" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions-1"><span class="mr-2">Conclusions</span><a href="#conclusions-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="appendix"><span class="mr-2">Appendix</span><a href="#appendix" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table A1</p><p>Relationship Between Categorized CD4 + Cell Count and Pattern of SIAs for Subgroup with Identical Magnetic Resonance Scanner ∗ ( <em>n</em> = 39)</p><p>CD4 + Cell Count (cells/μL) Pattern of SIAs ≥500 200–499 &lt;200 Multifocal ( <em>n</em> = 24) 8.3% 16.7% 75.0% Diffuse ( <em>n</em> = 15) 40.0% 26.7% 33.3%</p><p>Two-sided χ 2 test <em>P</em> = .021.</p><p>SIA, signal intensity abnormality.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table A2</p><p>Relationship Between Categorized CD4 + Cell Count and the Severity of BG SIAs for Subgroup with Identical Magnetic Resonance Scanner ∗ ( <em>n</em> = 39)</p><p>CD4 + Cell Count (cells/μL) Severity of BG SIAs ≥500 200–499 &lt;200 None ( <em>n</em> = 24) 29.2% 29.2% 41.6% Mild ( <em>n</em> = 10) 0.0% 10.0% 90.0% Moderate ( <em>n</em> = 5) 20.0% 0.0% 80.0% Severe ( <em>n</em> = 0) 0.0% 0.0% 0.0%</p><p>Two-sided χ 2 test <em>P</em> = .072.</p><p>BG, basal ganglia; SIA, signal intensity abnormality.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Smith A.B., Smirniotopoulos J.G., Rushing E.J.: From the archives of the AFIP: central nervous system infections associated with human immunodeficiency virus infection: radiologic-pathologic correlation. Radiographics 2008; 28: pp. 2033-2058.</p><li><p>2. Snider W.D., Simpson D.M., Nielsen S., et. al.: Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983; 14: pp. 403-418.</p><li><p>3. Davis L.E., Hjelle B.L., Miller V.E., et. al.: Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42: pp. 1736-1739.</p><li><p>4. Pomara N., Crandall D.T., Choi S.J., et. al.: White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res 2001; 106: pp. 15-24.</p><li><p>5. Thurnher M.M., Schindler E.G., Thurnher S.A., et. al.: Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course. AJNR Am J Neuroradiol 2000; 21: pp. 670-678.</p><li><p>6. Meltzer C.C., Wells S.W., Becher M.W., et. al.: AIDS-related MR hyperintensity of the basal ganglia. AJNR Am J Neuroradiol 1998; 19: pp. 83-89.</p><li><p>7. Thurnher M.M., Thurnher S.A., Fleischmann D., et. al.: Comparison of T2-weighted and fluid-attenuated inversion-recovery fast spin-echo MR sequences in intracerebral AIDS-associated disease. AJNR Am J Neuroradiol 1997; 18: pp. 1601-1609.</p><li><p>8. Broderick D.F., Wippold F.J., Clifford D.B., et. al.: White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol 1993; 161: pp. 177-181.</p><li><p>9. Bornstein R.A., Chakeres D., Brogan M., et. al.: Magnetic resonance imaging of white matter lesions in HIV infection. J Neuropsychiatry Clin Neurosci 1992; 4: pp. 174-178.</p><li><p>10. McArthur J.C., Kumar A.J., Johnson D.W., et. al.: Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1990; 3: pp. 252-259.</p><li><p>11. Olsen W.L., Longo F.M., Mills C.M., et. al.: White matter disease in AIDS: findings at MR imaging. Radiology 1988; 169: pp. 445-448.</p><li><p>12. Jernigan T.L., Archibald S., Hesselink J.R., et. al., The HNRC Group: Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol 1993; 50: pp. 250-255.</p><li><p>13. Schneider E., Whitmore S., Glynn K.M., et. al.: Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged &lt;18 months and for HIV infection and AIDS among children aged 18 months to &lt;13 years—United States, 2008. MMWR Recomm Rep 2008; 57: pp. 1-12.</p><li><p>14. Appel J., Potter E., Bhatia N., et. al.: Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009; 30: pp. 1870-1876.</p><li><p>15. Paul R., Cohen R., Navia B., et. al.: Relationships between cognition and structural neuroimaging findings in adults with human immunodeficiency virus type-1. Neurosci Biobehav Rev 2002; 26: pp. 353-359.</p><li><p>16. Albright A.V., Soldan S.S., Gonzalez-Scarano F.: Pathogenesis of human immunodeficiency virus-induced neurological disease. J Neurovirol 2003; 9: pp. 222-227.</p><li><p>17. Brew B.J., Pemberton L., Cunningham P., et. al.: Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175: pp. 963-966.</p><li><p>18. Moses A.V., Nelson J.A.: HIV infection of human brain capillary endothelial cells—implications for AIDS dementia. Adv Neuroimmunol 1994; 4: pp. 239-247.</p><li><p>19. Louboutin J.P., Reyes B.A., Agrawal L., et. al.: Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120—protection by gene delivery of antioxidant enzymes. Neurobiol Dis 2010; 38: pp. 313-325.</p><li><p>20. Berger J.R., Nath A., Greenberg R.N., et. al.: Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 2000; 54: pp. 921-926.</p><li><p>21. Glass J.D., Wesselingh S.L., Selnes O.A., et. al.: Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993; 43: pp. 2230-2237.</p><li><p>22. Antinori A., Giancola M.L., Grisetti S., et. al.: Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS 2002; 16: pp. 1867-1876.</p><li><p>23. Canestri A., Lescure F.X., Jaureguiberry S., et. al.: Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 2010; 50: pp. 773-778.</p><li><p>24. Eggers C., Hertogs K., Sturenburg H.J., et. al.: Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration. AIDS 2003; 17: pp. 1897-1906.</p><li><p>25. Maubon A.J., Ferru J.M., Berger V., et. al.: Effect of field strength on MR images: comparison of the same subject at 0.5, 1.0, and 1.5 T. Radiographics 1999; 19: pp. 1057-1067.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-18/'>Volume 18</a>, <a href='/categories/issue-9/'>Issue 9</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Cerebral%20Signal%20Intensity%20Abnormalities%20on%20T2-weighted%20MR%20Images%20in%20HIV%20Patients%20with%20Highly%20Active%20Antiretroviral%20Therapy%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Cerebral%20Signal%20Intensity%20Abnormalities%20on%20T2-weighted%20MR%20Images%20in%20HIV%20Patients%20with%20Highly%20Active%20Antiretroviral%20Therapy%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcerebral-signal-intensity-abnormalities-on-t2-weighted-mr-images-in-hiv-patients-with-highly-active%2F&text=Cerebral%20Signal%20Intensity%20Abnormalities%20on%20T2-weighted%20MR%20Images%20in%20HIV%20Patients%20with%20Highly%20Active%20Antiretroviral%20Therapy%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/235-minus-55-equals-180/"><div class="card-body"> <em class="small" data-ts="1314810000" data-df="ll" > Aug 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>235 Minus 55 Equals 180</h3><div class="text-muted small"><p> Last June, I agreed to start on a diet when my internist accused me of risking diabetes with excessive weight of 235 pounds at my advanced age. I wrote about my start in the Chronicle for the Novem...</p></div></div></a></div><div class="card"> <a href="/posts/a-pulmonary-nodule-view-system-for-the-lung-image-database-consortium-lidc/"><div class="card-body"> <em class="small" data-ts="1314810000" data-df="ll" > Aug 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Pulmonary Nodule View System for the Lung Image Database Consortium (LIDC)</h3><div class="text-muted small"><p> Rationale and Objectives The aim of this study was to develop a pulmonary nodule viewing system to visualize and retrieve data from the Lung Image Database Consortium. Materials and Methods The ...</p></div></div></a></div><div class="card"> <a href="/posts/accuracy-reproducibility-and-repeatability-of-ultrasonography-in-the-assessment-of-abdominal-adipos/"><div class="card-body"> <em class="small" data-ts="1314810000" data-df="ll" > Aug 31, 2011 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Accuracy, Reproducibility and Repeatability of Ultrasonography in the Assessment of Abdominal Adiposity</h3><div class="text-muted small"><p> Rationale and Objectives Despite improvements in the methods used in body composition analysis, some goals remain far from clinical practice. Among them, the most important is the quantification o...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/breast-imaging-the-requisites-2nd-edition/" class="btn btn-outline-primary" prompt="Older"><p>Breast Imaging The Requisites, 2nd Edition</p></a> <a href="/posts/characterization-and-detection-of-physiologic-lung-changes-before-and-after-placement-of-bronchial-v/" class="btn btn-outline-primary" prompt="Newer"><p>Characterization and Detection of Physiologic Lung Changes Before and After Placement of Bronchial Valves Using Hyperpolarized Helium-3 MR Imaging</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
